Purchases and Sales Made in Q4 2024 in Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND) during Q4 2024. The information is specifically focused on institutions that hold shares of Ascendis Pharma A/S.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
31.7K+ 1428.32% |
$3.87M - $4.65M
|
33.9K
$4.35M
|
|
Jan 24, 2025
Q4 2024
|
Abrdn PLC
|
BUY
|
- |
29K+ 18.31% |
$3.53M - $4.25M
|
187K
$24M
|
|
Jan 07, 2025
Q4 2024
|
Diversified Trust CO
|
BUY
|
- |
3.11K+ 7.43% |
$380K - $457K
|
45K
$5.77M
|
|
Jan 16, 2025
Q4 2024
|
Ars Investment Partners, LLC
|
BUY
|
- |
2.37K+ 0.9% |
$289K - $347K
|
265K
$34M
|
|
Jan 16, 2025
Q4 2024
|
Crossmark Global Holdings, Inc.
|
BUY
|
- |
2.32K+ 28.51% |
$282K - $339K
|
10.4K
$1.34M
|
|
Jan 23, 2025
Q4 2024
|
Gilbert & Cook, Inc.
|
BUY
|
- |
1.86K+ 72.49% |
$227K - $272K
|
4.42K
$567K
|
|
Jan 23, 2025
Q4 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
1.65K+ 14.78% |
$201K - $241K
|
12.8K
$1.64M
|
|
Jan 22, 2025
Q4 2024
|
Ronald Blue Trust, Inc.
Brentwood, TN |
BUY
|
- |
427+ 540.51% |
$52.1K - $62.6K
|
506
$64.9K
|
|
Jan 02, 2025
Q4 2024
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
214+ 57.99% |
$26.1K - $31.4K
|
583
$74.7K
|
|
Jan 15, 2025
Q4 2024
|
Skopos Labs, Inc.
Riverhead, NY |
BUY
|
- |
82New |
$10K - $12K
|
82
$10.5K
|
|
Jan 21, 2025
Q4 2024
|
Fifth Third Bancorp
|
BUY
|
- |
21+ 12.07% |
$2.56K - $3.08K
|
195
$25K
|
|
Jan 21, 2025
Q4 2024
|
Geneos Wealth Management Inc.
|
BUY
|
- |
1+ 1.33% |
$122 - $147
|
76
$9.74K
|
|
Jan 17, 2025
Q4 2024
|
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
Omaha, NE |
SELL
|
- |
-651- 7.93% |
$79.4K - $95.4K
|
7.56K
$969K
|
|
Jan 23, 2025
Q4 2024
|
Chicago Partners Investment Group LLC
|
SELL
|
- |
-850- 13.99% |
$104K - $125K
|
5.23K
$670K
|
|
Jan 10, 2025
Q4 2024
|
Harbor Capital Advisors, Inc.
|
SELL
|
- |
-2.43K- 2.78% |
$296K - $356K
|
84.9K
$10.9M
|
|
Jan 24, 2025
Q4 2024
|
Matisse Capital
|
SELL
|
- |
-3.19K- 9.46% |
$389K - $467K
|
30.5K
$3.91M
|